Eiger Biopharma (EIGR)

$1.73 0.00 (0.00%)
16:00 EDT EIGR Stock Quote Delayed 30 Minutes

Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?

By William White, InvestorPlace Writer
Eiger BioPharmaceuticals (EIGR) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 59.75M
PE Ratio -0.03
EPS -50.79
Volume (Avg. Vol.)
Day's Range -
52-Week Range $0.20 - $8.27
Dividend & Yield N/A (N/A)